{"id":"https://openalex.org/W1594089650","doi":"https://doi.org/10.1158/1538-7445.sabcs14-ot1-1-12","title":"Abstract OT1-1-12: A phase 3, open-label, randomized, parallel, 2-arm multi-center study of the oral PARP inhibitor BMN 673 versus physician's choice in germline BRCA mutation subjects with locally advanced and/or metastatic breast cancer (EMBRACA study)","display_name":"Abstract OT1-1-12: A phase 3, open-label, randomized, parallel, 2-arm multi-center study of the oral PARP inhibitor BMN 673 versus physician's choice in germline BRCA mutation subjects with locally advanced and/or metastatic breast cancer (EMBRACA study)","publication_year":2015,"publication_date":"2015-05-01","ids":{"openalex":"https://openalex.org/W1594089650","doi":"https://doi.org/10.1158/1538-7445.sabcs14-ot1-1-12","mag":"1594089650"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.sabcs14-ot1-1-12","doi":"https://doi.org/10.1158/1538-7445.sabcs14-ot1-1-12","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs14-ot1-1-12","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5014713051","display_name":"Jennifer Keating Litton","orcid":"https://orcid.org/0000-0001-8390-4985","observed_orcids":["https://orcid.org/0000-0001-8390-4985"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer K Litton","raw_affiliation_strings":["1MD Anderson Cancer Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1MD Anderson Cancer Center","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042123072","display_name":"Joanne Lorraine Blum","orcid":"https://orcid.org/0000-0002-7951-6645","observed_orcids":["https://orcid.org/0000-0002-7951-6645"]},"institutions":[{"id":"https://openalex.org/I2800124591","display_name":"Texas Oncology","ror":"https://ror.org/02ketev28","country_code":"US","type":"facility","lineage":["https://openalex.org/I2800124591"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joanne L Blum","raw_affiliation_strings":["2Baylor Sammons Cancer Center, Texas Oncology, US Oncology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Baylor Sammons Cancer Center, Texas Oncology, US Oncology","institution_ids":["https://openalex.org/I2800124591"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002412211","display_name":"Wolfgang EIERMANN","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wolfgang Eiermann","raw_affiliation_strings":["3Interdisziplinares Onkologisches Zentrum Munchen"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Interdisziplinares Onkologisches Zentrum Munchen","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089465499","display_name":"Young\u2010Hyuck Im","orcid":"https://orcid.org/0000-0001-6459-8118","observed_orcids":["https://orcid.org/0000-0001-6459-8118"]},"institutions":[{"id":"https://openalex.org/I2802194831","display_name":"Samsung Medical Center","ror":"https://ror.org/05a15z872","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I2250650973","https://openalex.org/I2802194831"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Young-Hyuck Im","raw_affiliation_strings":["4Samsung Medical Center","Samsung Medical Center#TAB#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Samsung Medical Center","institution_ids":["https://openalex.org/I2802194831"]},{"raw_affiliation_string":"Samsung Medical Center#TAB#","institution_ids":["https://openalex.org/I2802194831"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108721210","display_name":"Miguel Mart\u00edn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2960094004","display_name":"Hospital General Universitario Gregorio Mara\u00f1\u00f3n","ror":"https://ror.org/0111es613","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I2960094004","https://openalex.org/I4210139293"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Miguel Martin","raw_affiliation_strings":["5Hospital General Universitario Gregorio Mara\u00f1\u00f3n"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Hospital General Universitario Gregorio Mara\u00f1\u00f3n","institution_ids":["https://openalex.org/I2960094004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070265480","display_name":"Lida A. Mina","orcid":"https://orcid.org/0000-0003-2606-9922","observed_orcids":["https://orcid.org/0000-0003-2606-9922"]},"institutions":[{"id":"https://openalex.org/I4394709130","display_name":"Indiana University School of Medicine","ror":"https://ror.org/02ets8c94","country_code":"US","type":"education","lineage":["https://openalex.org/I4394709130","https://openalex.org/I592451"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lida Mina","raw_affiliation_strings":["6Indiana University School of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Indiana University School of Medicine","institution_ids":["https://openalex.org/I4394709130"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052648400","display_name":"Henri Hubert Roche","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210098740","display_name":"Institut universitaire du cancer de Toulouse Oncopole","ror":"https://ror.org/014hxhm89","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210098740","https://openalex.org/I4210128666"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Henri Roch\u00e9","raw_affiliation_strings":["7Institut Universitaire du Cancer Toulouse"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Institut Universitaire du Cancer Toulouse","institution_ids":["https://openalex.org/I4210098740"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090188675","display_name":"Hope S. Rugo","orcid":"https://orcid.org/0000-0001-6710-4814","observed_orcids":["https://orcid.org/0000-0001-6710-4814"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I4210167126","display_name":"UCSF Helen Diller Family Comprehensive Cancer Center","ror":"https://ror.org/05yndxy10","country_code":"US","type":"facility","lineage":["https://openalex.org/I180670191","https://openalex.org/I4210110664","https://openalex.org/I4210167126"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hope S Rugo","raw_affiliation_strings":["8UCSF Helen Diller Family Comprehensive Cancer Center","UCSF, Helen Diller Family Comprehensive Cancer Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"8UCSF Helen Diller Family Comprehensive Cancer Center","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210167126"]},{"raw_affiliation_string":"UCSF, Helen Diller Family Comprehensive Cancer Center","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210167126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111470192","display_name":"Frances M. Visco","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210121422","display_name":"National Cancer Coalition","ror":"https://ror.org/02fnsp050","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210121422"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Frances Visco","raw_affiliation_strings":["9National Breast Cancer Coalition"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"9National Breast Cancer Coalition","institution_ids":["https://openalex.org/I4210121422"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Charlie Zhang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I91786662","display_name":"BioMarin (United States)","ror":"https://ror.org/03fmvqd28","country_code":"US","type":"company","lineage":["https://openalex.org/I91786662"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charlie Zhang","raw_affiliation_strings":["10BioMarin Pharmaceutical Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"10BioMarin Pharmaceutical Inc","institution_ids":["https://openalex.org/I91786662"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074489260","display_name":"Nathalie Andrienne Lokker","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I91786662","display_name":"BioMarin (United States)","ror":"https://ror.org/03fmvqd28","country_code":"US","type":"company","lineage":["https://openalex.org/I91786662"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nathalie A Lokker","raw_affiliation_strings":["10BioMarin Pharmaceutical Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"10BioMarin Pharmaceutical Inc","institution_ids":["https://openalex.org/I91786662"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5070691408","display_name":"Debra L. Lounsbury","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I91786662","display_name":"BioMarin (United States)","ror":"https://ror.org/03fmvqd28","country_code":"US","type":"company","lineage":["https://openalex.org/I91786662"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Debra L Lounsbury","raw_affiliation_strings":["10BioMarin Pharmaceutical Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"10BioMarin Pharmaceutical Inc","institution_ids":["https://openalex.org/I91786662"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":10,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"75","issue":"9_Supplement","first_page":"OT1","last_page":"1"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/talazoparib","display_name":"talazoparib","score":0.9909999966621399},{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.7990000247955322},{"id":"https://openalex.org/keywords/germline-brca1-mutation","display_name":"germline BRCA1 mutation","score":0.9190000295639038},{"id":"https://openalex.org/keywords/germline-brca2-mutation","display_name":"germline BRCA2 mutation","score":0.9929999709129333},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.9539999961853027},{"id":"https://openalex.org/keywords/locally-advanced-breast-cancer","display_name":"locally advanced breast cancer","score":0.9879999756813049},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7440000176429749},{"id":"https://openalex.org/keywords/synthetic-lethality","display_name":"synthetic lethality","score":0.7059999704360962},{"id":"https://openalex.org/keywords/capecitabine","display_name":"capecitabine","score":0.7850000262260437},{"id":"https://openalex.org/keywords/eribulin","display_name":"eribulin","score":0.9700000286102295},{"id":"https://openalex.org/keywords/gemcitabine","display_name":"gemcitabine","score":0.9959999918937683},{"id":"https://openalex.org/keywords/vinorelbine","display_name":"vinorelbine","score":0.9980000257492065},{"id":"https://openalex.org/keywords/single-agent-chemotherapy","display_name":"single-agent chemotherapy","score":0.5180000066757202}],"concepts":[{"id":"https://openalex.org/C2779138821","wikidata":"https://www.wikidata.org/wiki/Q7118227","display_name":"PARP inhibitor","level":5,"score":0.751906156539917},{"id":"https://openalex.org/C2776387010","wikidata":"https://www.wikidata.org/wiki/Q408717","display_name":"Eribulin","level":5,"score":0.6745673418045044},{"id":"https://openalex.org/C2779962180","wikidata":"https://www.wikidata.org/wiki/Q7083106","display_name":"Olaparib","level":5,"score":0.6664853096008301},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6438689231872559},{"id":"https://openalex.org/C2778502085","wikidata":"https://www.wikidata.org/wiki/Q7662767","display_name":"Synthetic lethality","level":4,"score":0.6338828802108765},{"id":"https://openalex.org/C2778480876","wikidata":"https://www.wikidata.org/wiki/Q21112674","display_name":"PARP1","level":5,"score":0.5759932994842529},{"id":"https://openalex.org/C2780194787","wikidata":"https://www.wikidata.org/wiki/Q4836333","display_name":"BRCA mutation","level":4,"score":0.5385903120040894},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5273493528366089},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5045019388198853},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.47259506583213806},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4713522791862488},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.461361825466156},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.45975494384765625},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.43556761741638184},{"id":"https://openalex.org/C134935766","wikidata":"https://www.wikidata.org/wiki/Q210538","display_name":"DNA repair","level":3,"score":0.30767953395843506},{"id":"https://openalex.org/C182979987","wikidata":"https://www.wikidata.org/wiki/Q3907241","display_name":"Poly ADP ribose polymerase","level":4,"score":0.19001200795173645},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.183955579996109},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.16808286309242249},{"id":"https://openalex.org/C82381507","wikidata":"https://www.wikidata.org/wiki/Q416878","display_name":"Polymerase","level":3,"score":0.14892840385437012},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.10303756594657898}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.sabcs14-ot1-1-12","doi":"https://doi.org/10.1158/1538-7445.sabcs14-ot1-1-12","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs14-ot1-1-12","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1605656867","https://openalex.org/W2066767748","https://openalex.org/W2045777794","https://openalex.org/W2346607529","https://openalex.org/W2395647884","https://openalex.org/W2603397280","https://openalex.org/W2241624846","https://openalex.org/W2046389905","https://openalex.org/W2031205381","https://openalex.org/W2601536553"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Poly-ADP-ribose":[2],"polymerase":[3],"(PARP)":[4],"represents":[5],"a":[6,94,187,260,283],"family":[7],"of":[8,10,54,62,122,140,170,180,211,218,224,244,259,401,428],"enzymes":[9],"which":[11,55],"at":[12,83],"least":[13],"two":[14],"(PARP1":[15],"and":[16,45,96,101,138,209,221,298,357],"PARP2)":[17],"play":[18],"important":[19],"roles":[20],"in":[21,29,34,59,108,112,153,287,323,411],"DNA":[22,65],"repair.":[23,66],"PARP":[24,74,99,404],"inhibition":[25],"induces":[26],"synthetic":[27],"lethality":[28],"tumor":[30,110],"cells":[31],"bearing":[32],"mutations":[33],"the":[35,60,70,80,136,171,245,288,351,402,429],"genes":[36],"encoding":[37],"breast":[38,46,161,421],"cancer":[39,47,162,422],"susceptibility":[40,48],"gene":[41,49],"1":[42],"(BRCA":[43,51],"1)":[44],"2":[50,270],"2),":[52],"both":[53],"are":[56,233],"key":[57],"components":[58],"pathway":[61],"homologous":[63],"recombination":[64],"BMN":[67,91,141,184,212,315,406],"673":[68,92,142,185,316,407],"is":[69,93,133,173,347],"most":[71],"potent":[72,98],"preclinical":[73],"inhibitor":[75,100,405],"described":[76],"to":[77,134,174,190,312],"date":[78],"with":[79,163,183,193,282,416],"highest":[81],"efficiency":[82],"trapping":[84],"PARP-DNA":[85],"complexes":[86],"(Murai":[87],"et":[88],"al,":[89],"2014).":[90],"novel":[95],"highly":[97],"has":[102],"shown":[103],"promising":[104],"single-agent":[105],"anti-tumor":[106],"efficacy":[107,139],"several":[109],"types":[111],"an":[113],"ongoing":[114],"Phase":[115,129],"1/2":[116],"clinical":[117],"study.":[118],"Methods:":[119],"The":[120,167],"purpose":[121],"this":[123],"multi-center,":[124],"international,":[125],"open-label,":[126,395],"2:1":[127,311],"randomized":[128,310],"3":[130],"trial":[131,346],"(EMBRACA)":[132],"compare":[135,175],"safety":[137,208],"versus":[143,408],"protocol-specific":[144,194,327],"physician\u2019s":[145,195,328],"choice":[146,196,329,410],"treatment":[147,281,302,338],"(capecitabine,":[148],"eribulin,":[149],"gemcitabine":[150],"or":[151,236,240,262,266,290,326,342],"vinorelbine)":[152],"subjects":[154,181,333,415],"who":[155],"have":[156,238],"locally":[157,247,275,417],"advanced":[158,248,276,418],"and/or":[159,249,277,285,419],"metastatic":[160,250,278,291,304,420],"germline":[164,264,412],"BRCA":[165,413],"mutations.":[166],"primary":[168],"objective":[169,201],"study":[172,336,400],"progression":[176,341],"free":[177],"survival":[178,206],"(PFS)":[179],"treated":[182,192],"as":[186],"monotherapy":[188],"relative":[189],"those":[191],"treatment.":[197,330],"Secondary":[198],"objectives":[199,215],"include":[200,216],"response":[202,219],"rate":[203],"(ORR),":[204],"overall":[205],"(OS),":[207],"pharmacokinetics":[210],"673.":[213],"Exploratory":[214],"duration":[217],"(DOR)":[220],"health-related":[222],"quality":[223],"life":[225],"assessment.":[226],"Patients":[227,306],"may":[228],"be":[229,309],"eligible":[230,332],"if":[231],"they":[232],"18":[234],"years":[235],"older,":[237],"histologically":[239],"cytologically":[241],"confirmed":[242],"carcinoma":[243],"breast,":[246],"disease":[251,340],"appropriate":[252],"for":[253,274,303],"systemic":[254],"single":[255],"cytotoxic":[256],"chemotherapy,":[257],"documentation":[258],"deleterious":[261],"pathogenic":[263],"BRCA1":[265],"BRCA2":[267],"mutation,":[268],"\u2264":[269,296],"prior":[271,280,300],"chemotherapy-inclusive":[272],"regimens":[273],"disease,":[279],"taxane":[284],"anthracycline":[286],"adjuvant":[289],"setting,":[292],"ECOG":[293],"performance":[294],"status":[295],"1,":[297],"no":[299],"platinum":[301],"disease.":[305],"(n=429)":[307],"will":[308,334],"receive":[313,335],"either":[314],"oral":[317,403],"capsules":[318],"once":[319],"daily":[320],"(1.0":[321],"mg/day)":[322],"21-day":[324],"cycles":[325],"All":[331],"drug":[337],"until":[339],"unacceptable":[343],"toxicity.":[344],"This":[345],"enrolling":[348],"patients":[349],"from":[350],"United":[352],"States,":[353],"Europe,":[354],"Israel,":[355],"Asia/Pacific,":[356],"South":[358],"America":[359],"(NCT01945775).":[360],"Citation":[361],"Format:":[362],"Jennifer":[363],"K":[364],"Litton,":[365],"Joanne":[366],"L":[367,390],"Blum,":[368],"Wolfgang":[369],"Eiermann,":[370],"Young-Hyuck":[371],"Im,":[372],"Miguel":[373],"Martin,":[374],"Lida":[375],"Mina,":[376],"Henri":[377],"Roch\u00e9,":[378],"Hope":[379],"S":[380],"Rugo,":[381],"Frances":[382],"Visco,":[383],"Charlie":[384],"Zhang,":[385],"Nathalie":[386],"A":[387,392],"Lokker,":[388],"Debra":[389],"Lounsbury.":[391],"phase":[393],"3,":[394],"randomized,":[396],"parallel,":[397],"2-arm":[398],"multi-center":[399],"physician's":[409],"mutation":[414],"(EMBRACA":[423],"study)":[424],"[abstract].":[425],"In:":[426],"Proceedings":[427],"Thirty-Seventh":[430],"Annual":[431],"CTRC-AACR":[432],"San":[433,441],"Antonio":[434],"Breast":[435],"Cancer":[436,447],"Symposium:":[437],"2014":[438],"Dec":[439],"9-13;":[440],"Antonio,":[442],"TX.":[443],"Philadelphia":[444],"(PA):":[445],"AACR;":[446],"Res":[448],"2015;75(9":[449],"Suppl):Abstract":[450],"nr":[451],"OT1-1-12.":[452]},"counts_by_year":[{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2016-06-24T00:00:00"}